ERLOTIVA 150MG

Erlotiva 150mg Tablet is an anticancer medication that contains the active ingredient erlotinib. It is prescribed for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Cancer is characterized by the uncontrolled and abnormal proliferation of cells. This medication is typically administered alongside another anticancer drug, gemcitabine, for patients suffering from metastatic or advanced pancreatic cancers.

Patients should notify their doctor if they use contact lenses, have any intolerance to sugars, a history of eye issues, or clotting disorders, or if they are taking medications for clotting disorders or cholesterol. Erlotiva 150mg Tablet is not advised for adolescents and children under 18 years of age. It is important to avoid taking this medication with food. Effective birth control should be used during treatment and for at least two weeks following the final dose.